349.88
前日終値:
$343.30
開ける:
$342.99
24時間の取引高:
622.25K
Relative Volume:
0.37
時価総額:
$77.76B
収益:
$194.82B
当期純損益:
$5.53B
株価収益率:
14.31
EPS:
24.4514
ネットキャッシュフロー:
$3.77B
1週間 パフォーマンス:
+2.70%
1か月 パフォーマンス:
+3.36%
6か月 パフォーマンス:
-6.24%
1年 パフォーマンス:
-6.36%
Elevance Health Inc Stock (ELV) Company Profile
名前
Elevance Health Inc
セクター
電話
(800) 331-1476
住所
220 VIRGINIA AVENUE, INDIANAPOLIS
ELV を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
ELV
Elevance Health Inc
|
349.88 | 76.29B | 194.82B | 5.53B | 3.77B | 24.45 |
|
UNH
Unitedhealth Group Inc
|
331.83 | 296.73B | 435.16B | 18.37B | 17.37B | 19.16 |
|
CVS
Cvs Health Corp
|
79.61 | 100.44B | 393.94B | 428.00M | 6.29B | 0.3826 |
|
CI
Cigna Group
|
276.51 | 73.42B | 268.22B | 6.55B | 7.44B | 22.67 |
|
HUM
Humana Inc
|
258.83 | 31.18B | 126.36B | 1.30B | 1.55B | 10.67 |
Elevance Health Inc Stock (ELV) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-19 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2025-10-14 | 開始されました | Goldman | Neutral |
| 2025-07-21 | ダウングレード | Argus | Buy → Hold |
| 2025-07-18 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2025-04-15 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2025-03-17 | アップグレード | Argus | Hold → Buy |
| 2025-01-22 | ダウングレード | Stephens | Overweight → Equal-Weight |
| 2024-10-18 | ダウングレード | Argus | Buy → Hold |
| 2024-07-18 | ダウングレード | BofA Securities | Buy → Neutral |
| 2024-06-24 | 開始されました | Morgan Stanley | Overweight |
| 2024-05-30 | 開始されました | Robert W. Baird | Outperform |
| 2024-03-06 | 開始されました | Barclays | Overweight |
| 2023-07-12 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2023-04-27 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-21 | 開始されました | Cantor Fitzgerald | Overweight |
| 2023-03-28 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-09-09 | アップグレード | BofA Securities | Neutral → Buy |
| 2022-08-22 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
すべてを表示
Elevance Health Inc (ELV) 最新ニュース
Elevance Health Inc. stock outperforms competitors on strong trading day - MSN
Insurer Elevance Targets Out-Of-Network Care With Payment Cuts - InkFreeNews.com
AI Takes Center Stage at UNH: Will It Fix Administrative Waste? - TradingView — Track All Markets
Polianta Ltd Makes New Investment in Elevance Health, Inc. $ELV - MarketBeat
The past three years for Elevance Health (NYSE:ELV) investors has not been profitable - Yahoo Finance
Elevance Health (ELV) Stock: December 2025 Outlook After Q3 Earnings Beat, Legal Headwinds and New Analyst Targets - ts2.tech
Investment Recap: What insider trading reveals about Elevance Health Inc. stockJuly 2025 Snapshot & AI Powered Market Entry Ideas - moha.gov.vn
Asio Capital LLC Purchases 3,107 Shares of Elevance Health, Inc. $ELV - MarketBeat
ZWJ Investment Counsel Inc. Reduces Stake in Elevance Health, Inc. $ELV - MarketBeat
Elevance Health, Inc. $ELV Shares Bought by Hunter Perkins Capital Management LLC - MarketBeat
Swedbank AB Reduces Stake in Elevance Health, Inc. $ELV - MarketBeat
47,222 Shares in Elevance Health, Inc. $ELV Bought by Allen Mooney & Barnes Investment Advisors LLC - MarketBeat
Why a 63% Vertex Selloff Didn’t Scare Off a New $13 Million Investor - The Motley Fool
DAVENPORT & Co LLC Boosts Stock Position in Elevance Health, Inc. $ELV - MarketBeat
Elevance Health, Inc. $ELV Shares Sold by Voya Investment Management LLC - MarketBeat
What You Need To Know Ahead of Elevance Health’s Earnings Release - Yahoo Finance
Elevance Health, Inc. $ELV Stake Boosted by Exchange Traded Concepts LLC - MarketBeat
What Does the Market Think About Elevance Health Inc? - Sahm
How to listen to Elevance Health’s 2025 earnings call live - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elevance Health, Inc. (ELV) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Is Elevance Health Stock Outperforming the Nasdaq? - MSN
Signal Advisors Wealth LLC Has $2.08 Million Position in Elevance Health, Inc. $ELV - MarketBeat
Does Elevance Health (NYSE:ELV) Have A Healthy Balance Sheet? - Yahoo Finance
Castleview Partners LLC Has $2.15 Million Stake in Elevance Health, Inc. $ELV - MarketBeat
How Elevance Health Inc. (ELV) Affects Rotational Strategy Timing - Stock Traders Daily
Elevance Health Inc. stock underperforms Friday when compared to competitors - MarketWatch
Elevance Health (ELV) Rating Downgraded by Deutsche Bank | ELV S - GuruFocus
Will Elevance Health Inc. (A58) stock hit Wall Street targetsJuly 2025 Pullbacks & Free Expert Approved Momentum Trade Ideas - DonanımHaber
Wall Street sees an 18% upside to Elevance Health (ELV) - MSN
Deutsche Bank Downgrades Elevance Health to Hold From Buy, Adjusts Price Target to $320 From $332 - marketscreener.com
Deutsche Bank Downgrades Elevance Health to Hold From Buy, Trims Price Target to $320 From $332 - marketscreener.com
What sentiment indicators say about Elevance Health Inc. stockJuly 2025 Recap & Fast Moving Stock Trade Plans - DonanımHaber
Elevance Health, Inc. $ELV Shares Sold by Thrivent Financial for Lutherans - MarketBeat
Osaic Holdings Inc. Grows Stock Holdings in Elevance Health, Inc. $ELV - MarketBeat
BofA Adjusts Elevance Health (ELV) Target to Reflect Higher Sector Valuations - Insider Monkey
BofA adjusts Elevance Health (ELV) target to reflect higher sector valuations - MSN
How Elevance Health Inc. stock reacts to inflationary pressuresWeekly Profit Recap & Daily Profit Maximizing Tips - Улправда
Will Elevance Health Inc. (A58) stock enhance shareholder valueTreasury Yields & Risk Managed Investment Strategies - Улправда
Elevance Health, Inc. (ELV) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
How Elevance Health Inc. stock benefits from tech adoptionTrade Entry Report & AI Enhanced Execution Alerts - Улправда
Oak Thistle LLC Buys New Position in Elevance Health, Inc. $ELV - MarketBeat
Corient Private Wealth LLC Cuts Stock Position in Elevance Health, Inc. $ELV - MarketBeat
Elevance Health (NYSE:ELV) Price Target Lowered to $352.00 at Morgan Stanley - MarketBeat
Morgan Stanley Adjusts Price Target on Elevance Health to $352 From $359, Maintains Equalweight Rating - marketscreener.com
Wall Street Sees an 18% Upside to Elevance Health (ELV) - Finviz
Judge Allows Anthem $12.9 Million ERISA Settlement To Move Forward - marketscreener.com
Analysts Offer Insights on Healthcare Companies: Elevance Health (ELV), Argenx Se (ARGX) and Sarepta Therapeutics (SRPT) - The Globe and Mail
UnitedHealth, Elevance, Aetna tops in insurance market share: AMA - Modern Healthcare News
Texas Permanent School Fund Corp Trims Stock Holdings in Elevance Health, Inc. $ELV - MarketBeat
Assenagon Asset Management S.A. Increases Stake in Elevance Health, Inc. $ELV - MarketBeat
Elevance Health Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Elevance Health Inc (ELV) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):